Blood cancers

Osteoporosis drug may reveal leukaemia mechanism

The osteoporosis drug zoledronic acid may have potential in the treatment of leukaemia in children, researchers in WA have shown. Dr Laurence Cheung and co-researchers at the Telethon Kids Cancer Centre in Perth say pre-clinical findings suggest that targeting the microenvironment around leukaemia cells may not only help contain the malignancy but simultaneously provide relief ...

Already a member?

Login to keep reading.

© 2021 the limbic